Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $1.07 in the prior trading day, Standard BioTools Inc (NASDAQ: LAB) closed at $1.01, down -5.16%. In other words, the price has decreased by -$5.16 from its previous closing price. On the day, 3.2 million shares were traded.
Ratios:
Our goal is to gain a better understanding of LAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’24 when Black Jeffrey G. bought 57,971 shares for $2.12 per share.
Taich Adam bought 45,851 shares of LAB for $91,725 on Sep 09 ’24. On Aug 27 ’24, another insider, Casdin Partners Master Fund, L, who serves as the Director of the company, bought 250,000 shares for $2.19 each. As a result, the insider paid 546,750 and bolstered with 54,025,821 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.16 while its Price-to-Book (P/B) ratio in mrq is 0.77.
Stock Price History:
Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -37.22%, while the 200-Day Moving Average is calculated to be -46.80%.
Shares Statistics:
A total of 372.26M shares are outstanding, with a floating share count of 360.49M. Insiders hold about 3.16% of the company’s shares, while institutions hold 72.48% stake in the company.
